Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02557100 · ClinicalTrials.gov registry record · Phase 4
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
A Phase 4 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT02557100: Completed Phase 4 study, sponsored by Bristol-Myers Squibb.
NCT02557100 is a Phase 4 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 80 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02557100, a Phase 4 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to examine changes in immune cells and proteins in response to treatment with two approved therapies for Rheumatoid arthritis (RA), abatacept versus adalimumab, both given in combination with methotrexate.
Primary Outcome
Percentage of participants who experienced an AE
Interventions
- DRUG Abatacept
- DRUG Adalimumab
- DRUG Methotrexate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-11-19 |
| Est. Completion | 2019-03-28 |
| Phase | Phase 4 |
What the finished NCT02557100 record still lists
NCT02557100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Abatacept is the first listed.
NCT02557100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02557100 about?
NCT02557100 is a clinical study titled "Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis". The purpose of this study is to examine changes in immune cells and proteins in response to treatment with two approved therapies for Rheumatoid arthritis (RA), abatacept versus adalimumab, both given in combination with methotrexate.
What is the current status of trial NCT02557100?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2015-11-19. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT02557100?
The interventions under investigation include: Abatacept (DRUG), Adalimumab (DRUG), Methotrexate (DRUG).
Who is sponsoring clinical trial NCT02557100?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02557100's enrollment target sits among peer trials
80 946th of 2000 higher than 1,021 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI